Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation

Yubin Li, Mousa Komai-Koma, Derek S. Gilchrist, Daniel K. Hsu, Fu-Tong Liu, Tabitha Springall, Damo Xu

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Galectin-3 is a β-galactoside-binding lectin that plays an important role in inflammatory diseases. It also interacts with the surface carbohydrates of many pathogens, including LPS. However, its role in infection is not fully understood. Data presented herein demonstrate for the first time that galectin-3 is a negative regulator of LPS-induced inflammation. Galectin-3 is constitutively produced by macrophages and directly binds to LPS. Galectin-3-deficient macrophages had markedly elevated LPS-induced signaling and inflammatory cytokine production compared with wild-type cells, which was specifically inhibited by the addition of recombinant galectin-3 protein. In contrast, blocking galectin-3 binding sites by using a neutralizing Ab or its ligand, β-lactose, enhanced LPS-induced inflammatory cytokine expression by wild-type macrophages. In vivo, mice lacking galectin-3 were more susceptible to LPS shock associated with excessive induction of inflammatory cytokines and NO production. However, these changes conferred greater resistance to Salmonella infection. Thus, galectin-3 is a previously unrecognized, naturally occurring, negative regulator of LPS function, which protects the host from endotoxin shock but, conversely, favors Salmonella survival.

Original languageEnglish (US)
Pages (from-to)2781-2789
Number of pages9
JournalJournal of Immunology
Volume181
Issue number4
StatePublished - Aug 15 2008

Fingerprint

Galectin 3
Lipopolysaccharides
Inflammation
Macrophages
Cytokines
Shock
Galactosides
Salmonella Infections
Lactose
Lectins
Endotoxins
Salmonella
Binding Sites
Carbohydrates
Ligands

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Li, Y., Komai-Koma, M., Gilchrist, D. S., Hsu, D. K., Liu, F-T., Springall, T., & Xu, D. (2008). Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. Journal of Immunology, 181(4), 2781-2789.

Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. / Li, Yubin; Komai-Koma, Mousa; Gilchrist, Derek S.; Hsu, Daniel K.; Liu, Fu-Tong; Springall, Tabitha; Xu, Damo.

In: Journal of Immunology, Vol. 181, No. 4, 15.08.2008, p. 2781-2789.

Research output: Contribution to journalArticle

Li, Y, Komai-Koma, M, Gilchrist, DS, Hsu, DK, Liu, F-T, Springall, T & Xu, D 2008, 'Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation', Journal of Immunology, vol. 181, no. 4, pp. 2781-2789.
Li Y, Komai-Koma M, Gilchrist DS, Hsu DK, Liu F-T, Springall T et al. Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. Journal of Immunology. 2008 Aug 15;181(4):2781-2789.
Li, Yubin ; Komai-Koma, Mousa ; Gilchrist, Derek S. ; Hsu, Daniel K. ; Liu, Fu-Tong ; Springall, Tabitha ; Xu, Damo. / Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. In: Journal of Immunology. 2008 ; Vol. 181, No. 4. pp. 2781-2789.
@article{b51ffe9082bd4042a21707328e0f0892,
title = "Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation",
abstract = "Galectin-3 is a β-galactoside-binding lectin that plays an important role in inflammatory diseases. It also interacts with the surface carbohydrates of many pathogens, including LPS. However, its role in infection is not fully understood. Data presented herein demonstrate for the first time that galectin-3 is a negative regulator of LPS-induced inflammation. Galectin-3 is constitutively produced by macrophages and directly binds to LPS. Galectin-3-deficient macrophages had markedly elevated LPS-induced signaling and inflammatory cytokine production compared with wild-type cells, which was specifically inhibited by the addition of recombinant galectin-3 protein. In contrast, blocking galectin-3 binding sites by using a neutralizing Ab or its ligand, β-lactose, enhanced LPS-induced inflammatory cytokine expression by wild-type macrophages. In vivo, mice lacking galectin-3 were more susceptible to LPS shock associated with excessive induction of inflammatory cytokines and NO production. However, these changes conferred greater resistance to Salmonella infection. Thus, galectin-3 is a previously unrecognized, naturally occurring, negative regulator of LPS function, which protects the host from endotoxin shock but, conversely, favors Salmonella survival.",
author = "Yubin Li and Mousa Komai-Koma and Gilchrist, {Derek S.} and Hsu, {Daniel K.} and Fu-Tong Liu and Tabitha Springall and Damo Xu",
year = "2008",
month = "8",
day = "15",
language = "English (US)",
volume = "181",
pages = "2781--2789",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation

AU - Li, Yubin

AU - Komai-Koma, Mousa

AU - Gilchrist, Derek S.

AU - Hsu, Daniel K.

AU - Liu, Fu-Tong

AU - Springall, Tabitha

AU - Xu, Damo

PY - 2008/8/15

Y1 - 2008/8/15

N2 - Galectin-3 is a β-galactoside-binding lectin that plays an important role in inflammatory diseases. It also interacts with the surface carbohydrates of many pathogens, including LPS. However, its role in infection is not fully understood. Data presented herein demonstrate for the first time that galectin-3 is a negative regulator of LPS-induced inflammation. Galectin-3 is constitutively produced by macrophages and directly binds to LPS. Galectin-3-deficient macrophages had markedly elevated LPS-induced signaling and inflammatory cytokine production compared with wild-type cells, which was specifically inhibited by the addition of recombinant galectin-3 protein. In contrast, blocking galectin-3 binding sites by using a neutralizing Ab or its ligand, β-lactose, enhanced LPS-induced inflammatory cytokine expression by wild-type macrophages. In vivo, mice lacking galectin-3 were more susceptible to LPS shock associated with excessive induction of inflammatory cytokines and NO production. However, these changes conferred greater resistance to Salmonella infection. Thus, galectin-3 is a previously unrecognized, naturally occurring, negative regulator of LPS function, which protects the host from endotoxin shock but, conversely, favors Salmonella survival.

AB - Galectin-3 is a β-galactoside-binding lectin that plays an important role in inflammatory diseases. It also interacts with the surface carbohydrates of many pathogens, including LPS. However, its role in infection is not fully understood. Data presented herein demonstrate for the first time that galectin-3 is a negative regulator of LPS-induced inflammation. Galectin-3 is constitutively produced by macrophages and directly binds to LPS. Galectin-3-deficient macrophages had markedly elevated LPS-induced signaling and inflammatory cytokine production compared with wild-type cells, which was specifically inhibited by the addition of recombinant galectin-3 protein. In contrast, blocking galectin-3 binding sites by using a neutralizing Ab or its ligand, β-lactose, enhanced LPS-induced inflammatory cytokine expression by wild-type macrophages. In vivo, mice lacking galectin-3 were more susceptible to LPS shock associated with excessive induction of inflammatory cytokines and NO production. However, these changes conferred greater resistance to Salmonella infection. Thus, galectin-3 is a previously unrecognized, naturally occurring, negative regulator of LPS function, which protects the host from endotoxin shock but, conversely, favors Salmonella survival.

UR - http://www.scopus.com/inward/record.url?scp=53149147450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53149147450&partnerID=8YFLogxK

M3 - Article

C2 - 18684969

AN - SCOPUS:53149147450

VL - 181

SP - 2781

EP - 2789

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -